Home / Latest Reports / Personalized Medicine Market

Personalized Medicine Market by Product, Application, End User, Key Players and Regions - Global Industry Analysis & Forecast to 2027

Published On : August 2022 Pages : 165 Category: Pharma & Healthcare Report Code : HC0817411

Request Sample Inquiry Before Buying Request for Customization Check Discount

The global Personalized Medicine Market is valued at USD XX billion in 2021 and is projected to reach USD XX billion by the end of 2027, growing at a CAGR of XX% during the period 2022 to 2027.

The report exhibit detail coverage of Personalized Medicine industry and market trends. The report also analyses present and past market values to forecast potential market through the forecast period between 2017-2022. This research study of Personalized Medicine Market involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

In addition, the report provides insight into main drivers, challenges, opportunities and risk of the market and strategies of suppliers. Key players are profiled as well. Overall, this report covers the historical situation, present status and the future prospects of the global Personalized Medicine Market for 2017-2022.

Crystal Market Research envisions that the span of the Personalized Medicine Market will develop amid the estimated time frame as the Compound Annual Growth Rate boosts significantly. The objective of the market research report is the current status of the market and in accordance classifies it into a few portions. The report takes into consideration the prime market players in every area from over the globe.

Our research study analyses the size of the global market of Personalized Medicine in primary regions such as North America, South America, Middle East & Africa, Asia Pacific and Europe. It also classifies the Personalized Medicine Market by key manufacturers, region, type and application. Furthermore, this study examines in the status of the market, market share, future trends, growth rate, competitive landscape, opportunities, market driving factors and restraints, and challenges.

To stay updated with the latest technology and functions of the industry, Crystal Market Research regularly performs interviews with several industry experts and visits for its expert research analysts. The data sources include but not limited to reports of company’s, international organizations and governments, MMI market surveys, and related industry news.

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017 to 2027. This report has segmented the Personalized Medicine Market on the basis of fabric, product, application, and region:

By Region

  • North America (US, Canada)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Mexico, Columbia, Rest of South America)
  • Middle East and Africa (Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA)

Competitive Analysis                    

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Roche Holding AG
  • Astra Zeneca PLC
  • Vertex Pharmaceuticals Inc.
  • Qiagen Inc.
  • Becton Dickinson & Co., Merck & Co. Inc.
  • Pfizer Inc.
  • American Association for Cancer Research
  • iemens Healthcare Diagnostics, Inc.
  • GE Healthcare
  • Abbott

Market Classification

·        Personalized Medicine Market, By Product, Estimates and Forecast, 2017-2022 ($Million)

o   Diagnostics

o   Therapeutics

o   Medical Care

o   Nutrition & Wellness

·        Personalized Medicine Market, By Application, Estimates and Forecast, 2017-2022 ($Million)

o   Companion Diagnostics

o   Biomarker Identification

o   Health Informatics

o   Clinical Research

·        Personalized Medicine Market, By End User, Estimates and Forecast, 2017-2022 ($Million)

o   Hospitals and Clinics

o   Academic Institutes, Clinical Care and Research Laboratories

o   Contract Research Organizations

o   Others

Table of Contents

1.     Introduction

1.1.  Report Description

1.2.  Research Methodology

1.2.1.     Data Mining

1.2.2.     Market Modeling and Forecasting

1.2.3.     Data Validation

1.2.4.     Industry Analysis

2.     Market Dashboard

3.     Market Overview

3.1.  Introduction

3.1.1.     Market Definition

3.1.2.     Market Segmentation

3.2.  Market Dynamics

3.2.1.     Drivers

3.2.2.     Restraints

3.2.3.     Opportunities

3.2.4.     Challenges

4.     Personalized Medicine Market, By Product

4.1.  Introduction

4.2.  Personalized Medicine Market and Market Growth Rate By Product (2017-2022)

4.3.  Diagnostics

4.3.1.     Global Diagnostics Market and Growth Rate (2017-2022)

4.3.  Therapeutics

4.3.1.     Global Therapeutics Market and Growth Rate (2017-2022)

4.3.  Medical Care

4.3.1.     Global Medical Care Market and Growth Rate (2017-2022)

4.3.  Nutrition & Wellness

4.3.1.     Global Nutrition & Wellness Market and Growth Rate (2017-2022)

5.     Personalized Medicine Market, By Application

5.1.  Introduction

5.2.  Personalized Medicine Market and Market Growth Rate By Application (2017-2022)

5.3.  Companion Diagnostics

5.3.1.     Global Companion Diagnostics Market and Growth Rate (2017-2022)

5.3.  Biomarker Identification

5.3.1.     Global Biomarker Identification Market and Growth Rate (2017-2022)

5.3.  Health Informatics

5.3.1.     Global Health Informatics Market and Growth Rate (2017-2022)

5.3.  Clinical Research

5.3.1.     Global Clinical Research Market and Growth Rate (2017-2022)

6.     Personalized Medicine Market, By End User

6.1.  Introduction

6.2.  Personalized Medicine Market and Market Growth Rate By End User (2017-2022)

6.3.  Hospitals and Clinics

6.3.1.     Global Hospitals and Clinics Market and Growth Rate (2017-2022)

6.3.  Academic Institutes, Clinical Care and Research Laboratories

6.3.1.     Global Academic Institutes, Clinical Care and Research Laboratories Market and Growth Rate (2017-2022)

6.3.  Contract Research Organizations

6.3.1.     Global Contract Research Organizations Market and Growth Rate (2017-2022)

6.3.  Others

6.3.1.     Global Others Market and Growth Rate (2017-2022)

7.     Personalized Medicine Market, By Region

7.1.  Introduction

7.2.  Personalized Medicine Market and Growth Rate By Regions

6.3.  North America

7.3.1.     North America Personalized Medicine Market and Growth Rate (2017-2022))

7.3.2.     North America Personalized Medicine Market By Product (2017-2022)

7.3.2.     North America Personalized Medicine Market By Application (2017-2022)

7.3.2.     North America Personalized Medicine Market By End User (2017-2022)

7.3.4.     North America Personalized Medicine Market By Country (2017-2022)

7.3.5.     United States

7.3.5.1.United States Personalized Medicine Market and Growth Rate (2017-2022)

7.3.5.2.United States Personalized Medicine Market By Product (2017-2022)

7.3.5.2.United States Personalized Medicine Market By Application (2017-2022)

7.3.5.2.United States Personalized Medicine Market By End User (2017-2022)

7.3.5.     Canada

7.3.5.1.Canada Personalized Medicine Market and Growth Rate (2017-2022)

7.3.5.2.Canada Personalized Medicine Market By Product (2017-2022)

7.3.5.2.Canada Personalized Medicine Market By Application (2017-2022)

7.3.5.2.Canada Personalized Medicine Market By End User (2017-2022)

6.3.  Europe

8.3.1.     Europe Personalized Medicine Market and Growth Rate (2017-2022))

8.3.2.     Europe Personalized Medicine Market By Product (2017-2022)

8.3.2.     Europe Personalized Medicine Market By Application (2017-2022)

8.3.2.     Europe Personalized Medicine Market By End User (2017-2022)

8.3.4.     Europe Personalized Medicine Market By Country (2017-2022)

8.3.5.     Germany

8.3.5.1.Germany Personalized Medicine Market and Growth Rate (2017-2022)

8.3.5.2.Germany Personalized Medicine Market By Product (2017-2022)

8.3.5.2.Germany Personalized Medicine Market By Application (2017-2022)

8.3.5.2.Germany Personalized Medicine Market By End User (2017-2022)

8.3.5.     France

8.3.5.1.France Personalized Medicine Market and Growth Rate (2017-2022)

8.3.5.2.France Personalized Medicine Market By Product (2017-2022)

8.3.5.2.France Personalized Medicine Market By Application (2017-2022)

8.3.5.2.France Personalized Medicine Market By End User (2017-2022)

8.3.5.     UK

8.3.5.1.UK Personalized Medicine Market and Growth Rate (2017-2022)

8.3.5.2.UK Personalized Medicine Market By Product (2017-2022)

8.3.5.2.UK Personalized Medicine Market By Application (2017-2022)

8.3.5.2.UK Personalized Medicine Market By End User (2017-2022)

8.3.5.     Russia

8.3.5.1.Russia Personalized Medicine Market and Growth Rate (2017-2022)

8.3.5.2.Russia Personalized Medicine Market By Product (2017-2022)

8.3.5.2.Russia Personalized Medicine Market By Application (2017-2022)

8.3.5.2.Russia Personalized Medicine Market By End User (2017-2022)

8.3.5.     Italy

8.3.5.1.Italy Personalized Medicine Market and Growth Rate (2017-2022)

8.3.5.2.Italy Personalized Medicine Market By Product (2017-2022)

8.3.5.2.Italy Personalized Medicine Market By Application (2017-2022)

8.3.5.2.Italy Personalized Medicine Market By End User (2017-2022)

8.3.5.     Rest of Europe

8.3.5.1.Rest of Europe Personalized Medicine Market and Growth Rate (2017-2022)

8.3.5.2.Rest of Europe Personalized Medicine Market By Product (2017-2022)

8.3.5.2.Rest of Europe Personalized Medicine Market By Application (2017-2022)

8.3.5.2.Rest of Europe Personalized Medicine Market By End User (2017-2022)

6.3.  Asia-Pacific

9.3.1.     Asia-Pacific Personalized Medicine Market and Growth Rate (2017-2022))

9.3.2.     Asia-Pacific Personalized Medicine Market By Product (2017-2022)

9.3.2.     Asia-Pacific Personalized Medicine Market By Application (2017-2022)

9.3.2.     Asia-Pacific Personalized Medicine Market By End User (2017-2022)

9.3.4.     Asia-Pacific Personalized Medicine Market By Country (2017-2022)

9.3.5.     China

9.3.5.1.China Personalized Medicine Market and Growth Rate (2017-2022)

9.3.5.2.China Personalized Medicine Market By Product (2017-2022)

9.3.5.2.China Personalized Medicine Market By Application (2017-2022)

9.3.5.2.China Personalized Medicine Market By End User (2017-2022)

9.3.5.     Japan

9.3.5.1.Japan Personalized Medicine Market and Growth Rate (2017-2022)

9.3.5.2.Japan Personalized Medicine Market By Product (2017-2022)

9.3.5.2.Japan Personalized Medicine Market By Application (2017-2022)

9.3.5.2.Japan Personalized Medicine Market By End User (2017-2022)

9.3.5.     Korea

9.3.5.1.Korea Personalized Medicine Market and Growth Rate (2017-2022)

9.3.5.2.Korea Personalized Medicine Market By Product (2017-2022)

9.3.5.2.Korea Personalized Medicine Market By Application (2017-2022)

9.3.5.2.Korea Personalized Medicine Market By End User (2017-2022)

9.3.5.     India

9.3.5.1.India Personalized Medicine Market and Growth Rate (2017-2022)

9.3.5.2.India Personalized Medicine Market By Product (2017-2022)

9.3.5.2.India Personalized Medicine Market By Application (2017-2022)

9.3.5.2.India Personalized Medicine Market By End User (2017-2022)

9.3.5.     Southeast Asia

9.3.5.1.Southeast Asia Personalized Medicine Market and Growth Rate (2017-2022)

9.3.5.2.Southeast Asia Personalized Medicine Market By Product (2017-2022)

9.3.5.2.Southeast Asia Personalized Medicine Market By Application (2017-2022)

9.3.5.2.Southeast Asia Personalized Medicine Market By End User (2017-2022)

9.3.5.     Rest of Asia-Pacific

9.3.5.1.Rest of Asia-Pacific Personalized Medicine Market and Growth Rate (2017-2022)

9.3.5.2.Rest of Asia-Pacific Personalized Medicine Market By Product (2017-2022)

9.3.5.2.Rest of Asia-Pacific Personalized Medicine Market By Application (2017-2022)

9.3.5.2.Rest of Asia-Pacific Personalized Medicine Market By End User (2017-2022)

6.3.  South America

10.3.1.     South America Personalized Medicine Market and Growth Rate (2017-2022))

10.3.2.     South America Personalized Medicine Market By Product (2017-2022)

10.3.2.     South America Personalized Medicine Market By Application (2017-2022)

10.3.2.     South America Personalized Medicine Market By End User (2017-2022)

10.3.4.     South America Personalized Medicine Market By Country (2017-2022)

10.3.5.     Brazil

10.3.5.1.Brazil Personalized Medicine Market and Growth Rate (2017-2022)

10.3.5.2.Brazil Personalized Medicine Market By Product (2017-2022)

10.3.5.2.Brazil Personalized Medicine Market By Application (2017-2022)

10.3.5.2.Brazil Personalized Medicine Market By End User (2017-2022)

10.3.5.     Mexico

10.3.5.1.Mexico Personalized Medicine Market and Growth Rate (2017-2022)

10.3.5.2.Mexico Personalized Medicine Market By Product (2017-2022)

10.3.5.2.Mexico Personalized Medicine Market By Application (2017-2022)

10.3.5.2.Mexico Personalized Medicine Market By End User (2017-2022)

10.3.5.     Columbia

10.3.5.1.Columbia Personalized Medicine Market and Growth Rate (2017-2022)

10.3.5.2.Columbia Personalized Medicine Market By Product (2017-2022)

10.3.5.2.Columbia Personalized Medicine Market By Application (2017-2022)

10.3.5.2.Columbia Personalized Medicine Market By End User (2017-2022)

10.3.5.     Rest of South America

10.3.5.1.Rest of South America Personalized Medicine Market and Growth Rate (2017-2022)

10.3.5.2.Rest of South America Personalized Medicine Market By Product (2017-2022)

10.3.5.2.Rest of South America Personalized Medicine Market By Application (2017-2022)

10.3.5.2.Rest of South America Personalized Medicine Market By End User (2017-2022)

6.3.  Middle East and Africa

11.3.1.     Middle East and Africa Personalized Medicine Market and Growth Rate (2017-2022))

11.3.2.     Middle East and Africa Personalized Medicine Market By Product (2017-2022)

11.3.2.     Middle East and Africa Personalized Medicine Market By Application (2017-2022)

11.3.2.     Middle East and Africa Personalized Medicine Market By End User (2017-2022)

11.3.4.     Middle East and Africa Personalized Medicine Market By Country (2017-2022)

11.3.5.     Saudi Arabia

11.3.5.1.Saudi Arabia Personalized Medicine Market and Growth Rate (2017-2022)

11.3.5.2.Saudi Arabia Personalized Medicine Market By Product (2017-2022)

11.3.5.2.Saudi Arabia Personalized Medicine Market By Application (2017-2022)

11.3.5.2.Saudi Arabia Personalized Medicine Market By End User (2017-2022)

11.3.5.     United Arab Emirates

11.3.5.1.United Arab Emirates Personalized Medicine Market and Growth Rate (2017-2022)

11.3.5.2.United Arab Emirates Personalized Medicine Market By Product (2017-2022)

11.3.5.2.United Arab Emirates Personalized Medicine Market By Application (2017-2022)

11.3.5.2.United Arab Emirates Personalized Medicine Market By End User (2017-2022)

11.3.5.     South Africa

11.3.5.1.South Africa Personalized Medicine Market and Growth Rate (2017-2022)

11.3.5.2.South Africa Personalized Medicine Market By Product (2017-2022)

11.3.5.2.South Africa Personalized Medicine Market By Application (2017-2022)

11.3.5.2.South Africa Personalized Medicine Market By End User (2017-2022)

11.3.5.     Rest of Middle East and Africa

11.3.5.1.Rest of Middle East and Africa Personalized Medicine Market and Growth Rate (2017-2022)

11.3.5.2.Rest of Middle East and Africa Personalized Medicine Market By Product (2017-2022)

11.3.5.2.Rest of Middle East and Africa Personalized Medicine Market By Application (2017-2022)

11.3.5.2.Rest of Middle East and Africa Personalized Medicine Market By End User (2017-2022)

7.     Company Profiles

7.1.  Roche Holding AG

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Astra Zeneca PLC

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Vertex Pharmaceuticals Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Qiagen Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Becton Dickinson & Co., Merck & Co. Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Pfizer Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  American Association for Cancer Research

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  iemens Healthcare Diagnostics, Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  GE Healthcare

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Abbott

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*